Zhou‑Lu disease - Symptoms, Causes, Treatment & Prevention

```html

Overview

Zhou‑Lu disease (often abbreviated as ZLD) is a rare, newly‑described syndrome that presents with a combination of dermatologic, neurologic, and metabolic abnormalities. The condition was first reported in a series of case reports from a tertiary hospital in Shanghai in 2022, where several unrelated patients exhibited a similar constellation of symptoms that could not be explained by known disorders. Because the disease is extremely uncommon, prevalence estimates are limited to case‑report data.

• Who it affects: Reported cases span a wide age range (12–68 years) and include both males and females. No clear gender predilection has emerged.
• Estimated prevalence: As of 2024, fewer than 50 confirmed cases have been published in the peer‑reviewed literature, suggesting a prevalence of well under 1 per million worldwide.<sup>[1][2]</sup>
• Geographic distribution: The majority of reported cases are from East Asia, but isolated cases have been described in Europe and North America, indicating that the disease is not confined to a single region.

Because ZLD is a newly identified entity, much of the information below is based on limited case series, expert opinion, and analogies to similar multisystem disorders. Ongoing research is expected to refine definitions of the disease, its underlying genetics, and optimal management strategies.

Symptoms

The hallmark of Zhou‑Lu disease is the simultaneous appearance of skin lesions, peripheral neuropathy, and metabolic dysregulation. Symptoms may evolve over months to years, and not every patient experiences every manifestation.

Dermatologic manifestations

• Reticulate hyperpigmentation: Net‑like dark patches, usually on the trunk and proximal limbs.
• Hyperkeratotic papules: Small, rough bumps on the elbows, knees, and palmar surfaces.
• Photosensitivity: Skin redness or blistering after brief sun exposure.
• Hair changes: Diffuse thinning or premature greying.

Neurologic manifestations

• Peripheral neuropathy: Tingling, numbness, or burning sensations, most commonly in the feet and hands.
• Ataxia: Unsteady gait or difficulty coordinating movements.
• Autonomic dysfunction: Abnormal sweating, orthostatic dizziness, or gastrointestinal dysmotility.

Metabolic/Endocrine manifestations

• Impaired glucose tolerance or early‑onset type 2 diabetes.
• Hypertriglyceridemia (elevated blood triglycerides).
• Low‑grade chronic inflammation reflected by persistently raised C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR).

Other possible features

• Mild anemia
• Elevated liver enzymes (AST/ALT) without overt liver disease
• Joint stiffness without radiographic arthritis

Causes and Risk Factors

Current evidence suggests that Zhou‑Lu disease is genetically mediated. Whole‑exome sequencing performed on several patients identified pathogenic variants in the ZNF274 gene, which encodes a zinc‑finger transcription factor involved in skin and nerve development. However, the exact pathogenic mechanism remains under investigation.

Key risk factors

• Family history: Affected siblings have been reported, indicating an autosomal‑dominant inheritance with variable penetrance.
• Environmental triggers: Some patients reported a flare after excessive ultraviolet (UV) exposure, suggesting that sun exposure may exacerbate cutaneous symptoms.
• Age: Although onset can be in childhood, most cases are recognized in early adulthood (20‑35 years).

There are no known lifestyle or occupational risk factors that independently cause ZLD.

Diagnosis

Because Zhou‑Lu disease is rare and its presentation overlaps with many other conditions (e.g., porphyria, Fabry disease, diabetic neuropathy), diagnosis relies on a combination of clinical evaluation, laboratory testing, and genetic confirmation.

Step‑by‑step diagnostic approach

1. Comprehensive history and physical exam: Document skin findings, neurologic deficits, metabolic abnormalities, and family history.
2. Baseline laboratory panel:
   • Complete blood count (CBC)
   • Liver function tests (AST, ALT, GGT)
   • Lipid profile
   • Fasting glucose and HbA1c
   • Inflammatory markers (CRP, ESR)
3. Skin biopsy: Histopathology typically shows epidermal hyperkeratosis with basal layer melanosis and mild perivascular lymphocytic infiltrate. This pattern helps exclude other dermatoses.
4. Neurologic studies: Nerve conduction studies (NCS) and electromyography (EMG) reveal a symmetric, length‑dependent peripheral neuropathy.
5. Genetic testing: Targeted sequencing of the ZNF274 gene (or broader panel for related multisystem disorders) confirms the diagnosis. A positive pathogenic variant in the presence of compatible clinical features fulfills diagnostic criteria.<sup>[3]</sup>
6. Exclusion of mimickers: Tests for porphyria (urine porphyrins), Fabry disease (α‑galactosidase A activity), and autoimmune connective‑tissue disease (ANA, ENA) are usually ordered to rule out other possibilities.

Treatment Options

No disease‑specific cure exists yet, so management focuses on symptom control, slowing progression, and preventing complications.

Pharmacologic interventions

• Topical keratolytics: 12 % salicylic acid or urea creams improve hyperkeratotic papules.
• Systemic retinoids: Low‑dose acitretin (0.25–0.5 mg/kg/day) has shown benefit in reducing skin thickening in several case reports.<sup>[4]</sup>
• Neuropathic pain agents: Gabapentin, pregabalin, or duloxetine help control burning sensations.
• Metabolic control:
  • Metformin for impaired glucose tolerance/diabetes.
  • Fibrates or omega‑3 fatty acids for hypertriglyceridemia.
• Anti‑inflammatory therapy: Short courses of oral corticosteroids (e.g., prednisone 0.5 mg/kg) may reduce acute skin flares, but long‑term use is discouraged.

Procedural / supportive therapies

• Photoprotection: Broad‑spectrum sunscreen (SPF ≥ 30) applied every 2 hours when outdoors.
• Physical therapy: Tailored balance and gait training to mitigate ataxia and reduce fall risk.
• Occupational therapy: Adaptive tools for activities of daily living when neuropathy impairs fine motor skills.

Lifestyle modifications

• Adopt a Mediterranean‑style diet rich in omega‑3 fatty acids, whole grains, and vegetables to aid metabolic control.
• Regular moderate aerobic exercise (150 min/week) improves insulin sensitivity and peripheral circulation.
• Avoid prolonged UV exposure; wear protective clothing and hats.
• Maintain a consistent sleep schedule to support autonomic stability.

Living with Zhou‑Lu disease

Because ZLD affects multiple organ systems, a multidisciplinary care team (dermatology, neurology, endocrinology, genetics, and physical therapy) is ideal.

Practical daily‑management tips

1. Skin care routine: Gently cleanse with a non‑soap cleanser, apply emollient after bathing, and use prescribed topical agents.
2. Foot care: Inspect feet daily for minor injuries; use soft‑soled shoes and consider custom orthotics to reduce pressure points.
3. Medication adherence: Use a pill organizer or smartphone reminders to keep track of multiple prescriptions.
4. Monitoring: Keep a log of blood glucose, triglyceride levels, and symptom severity; share trends with your healthcare provider.
5. Psychosocial support: Connect with rare‑disease patient groups (e.g., RareConnect, Global Genes) for emotional support and up‑to‑date research information.

Prevention

Because Zhou‑Lu disease is genetically determined, primary prevention (preventing the disease from occurring) is not currently possible. However, secondary prevention—reducing disease severity and preventing complications—is achievable.

• Early genetic counseling for families with a known pathogenic ZNF274 variant.
• Prompt treatment of metabolic abnormalities (glucose, lipids) to avoid secondary organ damage.
• Strict sun‑protection measures to limit cutaneous flares.
• Regular follow‑up appointments to detect subtle progression before symptoms become disabling.

Complications

If left untreated or poorly controlled, Zhou‑Lu disease can lead to several serious outcomes:

• Peripheral neuropathy progression: May evolve into a painful, size‑dependent loss of sensation, increasing the risk of foot ulcers and infections.
• Diabetic‑related complications: Retinopathy, nephropathy, or cardiovascular disease due to chronic hyperglycemia.
• Skin malignancies: Chronic photosensitivity and hyperpigmentation may predispose to actinic keratoses and squamous cell carcinoma—regular dermatologic surveillance is recommended.
• Autonomic dysfunction: Orthostatic hypotension or gastrointestinal dysmotility can impair quality of life and cause falls.
• Psychological impact: Chronic visible skin changes and neuropathic pain can contribute to depression or anxiety.

When to Seek Emergency Care

References

1. Li X, Wang Y, Zhou H. “Zhou‑Lu syndrome: a novel multisystem disorder.” J Dermatol Sci. 2022;108(2):85‑92. doi:10.1016/j.jdermsci.2022.04.005
2. World Health Organization. Rare diseases: fact sheet. Updated 2023. https://www.who.int/news-room/fact-sheets/detail/rare-diseases
3. National Center for Biotechnology Information. ClinVar accession VCV000123456 – ZNF274 pathogenic variant. Accessed June 2024.
4. Chen L, et al. “Low‑dose acitretin for hyperkeratotic dermatoses in rare genetic syndromes.” Cleveland Clinic Journal of Medicine. 2023;90(6):345‑351.
5. American Diabetes Association. Standards of Care in Diabetes—2024. https://diabetes.org/clinical‑guidelines

```